David Hilfiker (Dave) is an experienced leader in the pharmaceutical industry, currently serving as Senior Director, Head of RBQM at Daiichi Sankyo. He is known for applying his experience to optimize quality and speed during clinical development, leading to successful regulatory submissions and inspections. Dave stands out for his combined experiences in new drug review at the FDA and in industry regulatory affairs and R&D quality and compliance, making him a unique communicator within the field.
Dave is passionate about the pursuit of balance between competing forces (e.g., work and play, innovation and execution, art and science), incorporating this pursuit into personal and professional interests. He is above all family first – proud to be a husband and father to three fantastic young adults, a dog and a cat.